The Cooper Companies, Inc. (COO) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $71.61. It has a SharesGrow Score of 66/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of COO = $111.59 (+55.8% from the current price, the stock appears undervalued). Analyst consensus target is COO = $94 (+31.1% upside).
Valuation: COO trades at a trailing Price-to-Earnings (P/E) of 34.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.88.
Financials: revenue is $4.1B, +7.4%/yr average growth. Net income is $375M, growing at +1.7%/yr. Net profit margin is 9.2% (thin). Gross margin is 60.7% (-4 pp trend).
Balance sheet: total debt is $2.8B against $8.2B equity (Debt-to-Equity (D/E) ratio 0.34, conservative). Current ratio is 1.89 (strong liquidity). Debt-to-assets is 22.5%. Total assets: $12.4B.
Analyst outlook: 15 / 24 analysts rate COO as buy (63%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 36/100 (Fail), Growth 55/100 (Partial), Past 100/100 (Pass), Health 83/100 (Pass), Moat 71/100 (Pass), Future 73/100 (Pass), Income 45/100 (Partial).
